159 related articles for article (PubMed ID: 32004537)
1. Transitioning Chemistry, Manufacturing, and Controls Content With a Structured Data Management Solution: Streamlining Regulatory Submissions.
Algorri M; Cauchon NS; Abernathy MJ
J Pharm Sci; 2020 Apr; 109(4):1427-1438. PubMed ID: 32004537
[TBL] [Abstract][Full Text] [Related]
2. The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data Management.
Ahluwalia K; Abernathy MJ; Beierle J; Cauchon NS; Cronin D; Gaiki S; Lennard A; Mady P; McGorry M; Sugrue-Richards K; Xue G
J Pharm Sci; 2022 May; 111(5):1232-1244. PubMed ID: 34610323
[TBL] [Abstract][Full Text] [Related]
3. Structured content and data management-enhancing acceleration in drug development through efficiency in data exchange.
Beierle J; Algorri M; Cortés M; Cauchon NS; Lennard A; Kirwan JP; Oghamian S; Abernathy MJ
AAPS Open; 2023; 9(1):11. PubMed ID: 37193559
[TBL] [Abstract][Full Text] [Related]
4. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
Steinwandter V; Herwig C
PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
[TBL] [Abstract][Full Text] [Related]
5. Extent and content of data for regulatory submissions: First-in-human and marketing authorization--Viewpoint of US industry.
Harris IR
Biologicals; 2015 Sep; 43(5):402-5. PubMed ID: 26088904
[TBL] [Abstract][Full Text] [Related]
6. "Guidance for industry: content and format of chemistry, manufacturing and controls information and establishment description information for a biological in vitro diagnostic product;" availability. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 Mar; 64(44):11023-4. PubMed ID: 10557623
[TBL] [Abstract][Full Text] [Related]
7. Meeting report: Advancing accelerated regulatory review with Real-Time Oncology Review (RTOR), Project Orbis, and the Product Quality Assessment Aid.
Algorri M; Acharya A; Bernstein J; Cauchon NS; Chen XH; Huynh-Ba K; Krantz C; Li T; Li Y; McLamore S; Roberts SW; Schwinke D; Shah R; Schirmer A; Strickland H; Tang K; Watson T
AAPS Open; 2022; 8(1):19. PubMed ID: 36530577
[TBL] [Abstract][Full Text] [Related]
8. Expedited Programs for Serious Conditions: An Update on Breakthrough Therapy Designation.
Kwok M; Foster T; Steinberg M
Clin Ther; 2015 Sep; 37(9):2104-20. PubMed ID: 26297571
[TBL] [Abstract][Full Text] [Related]
9. Real-time algorithmic exchange and processing of pharmaceutical quality data and information.
Anderson C; Algorri M; Abernathy MJ
Int J Pharm; 2023 Oct; 645():123342. PubMed ID: 37619807
[TBL] [Abstract][Full Text] [Related]
10. Regulatory administrative databases in FDA's Center for Biologics Evaluation and Research: convergence toward a unified database.
Smith JK
AAPS J; 2013 Apr; 15(2):388-94. PubMed ID: 23269527
[TBL] [Abstract][Full Text] [Related]
11. PDA Biosimilars Workshop Report (September 27-28, 2018)-Getting It Right the First Time for Biosimilar Marketing Applications.
Krause S; Lacana E; Welch J; Shapiro M; Downey C; Chung J; Zhou Q; Van Der Plas M; Depatie C; Ingram B; Srebalus-Barnes C; Polozova A; Rellahan B; Choi D; Burdick R; Stangler T; Shacter E
PDA J Pharm Sci Technol; 2019; 73(4):401-416. PubMed ID: 31004040
[TBL] [Abstract][Full Text] [Related]
12. Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines.
Popkin ME; Goese M; Wilkinson D; Finnie S; Flanagan T; Campa C; Clinch A; Teasdale A; Lennard A; Cook G; Mohan G; Osborne MD
AAPS J; 2022 Sep; 24(6):101. PubMed ID: 36168002
[TBL] [Abstract][Full Text] [Related]
13. "Guidance for Industry: On the Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for an Allergenic Extract or Allergen Patch Test"; availability. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 Apr; 64(78):20006-7. PubMed ID: 10558479
[TBL] [Abstract][Full Text] [Related]
14. Awareness of the role of science in the FDA regulatory submission process: a survey of the TERMIS-Americas membership.
Johnson PC; Bertram TA; Carty NR; Hellman KB; Tawil BJ; Van Dyke M
Tissue Eng Part A; 2014 Jun; 20(11-12):1565-82. PubMed ID: 24665855
[TBL] [Abstract][Full Text] [Related]
15. A network of regulatory innovations to improve FDA quality assessments of human drug applications.
Tran R; Fraser G; Fisher AC; Lee SL; Boam A; Tsinontides S; Maguire J; Yu LX; Rosencrance S; Kozlowski S; Henry D
Int J Pharm X; 2024 Jun; 7():100239. PubMed ID: 38545329
[TBL] [Abstract][Full Text] [Related]
16. "Guidance for Industry: For the Submission of Chemistry, Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion or for Further Manufacture and for the Completion of the Form FDA 356h, 'Application to Market a New Drug, Biologic or an Antibiotic Drug for Human Use;'" availability. Food and Drug Administration, HHS. Notice.
Fed Regist; 1999 May; 64(89):25049-50. PubMed ID: 10558535
[TBL] [Abstract][Full Text] [Related]
17. Predictive Analysis of First Abbreviated New Drug Application Submission for New Chemical Entities Based on Machine Learning Methodology.
Hu M; Babiskin A; Wittayanukorn S; Schick A; Rosenberg M; Gong X; Kim MJ; Zhang L; Lionberger R; Zhao L
Clin Pharmacol Ther; 2019 Jul; 106(1):174-181. PubMed ID: 31009066
[TBL] [Abstract][Full Text] [Related]
18. Strategies for Accelerated Drug Development: An Industry Perspective Based on an IQ Consortium Survey of CMC Considerations.
Buist N; Krzyzaniak J; Abbas S; Alvarez-Nunez F; Bell S; Chen B; Chen G; Chen S; He M; Hutchens C; Ibrahim B; Ingram R; Kulkarni M; Murthy A; Tan DCT; Sood R; Ying W; Roopwani R
J Pharm Sci; 2024 Jun; ():. PubMed ID: 38862091
[TBL] [Abstract][Full Text] [Related]
19. Generic Pharmaceutical Association (GPhA) - 2015 CMC Workshop (June 9-10, 2015 - Bethesda, Maryland, USA).
Komlos D
Drugs Today (Barc); 2015 Jul; 51(7):429-40. PubMed ID: 26261845
[TBL] [Abstract][Full Text] [Related]
20. US FDA 505(b)(2) NDA clinical, CMC and regulatory strategy concepts to expedite drug development.
Salminen WF; Aloba O; Drew A; Marcinowicz A; Huang M
Drug Discov Today; 2023 Jul; 28(7):103618. PubMed ID: 37196760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
